-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Maintains Neutral on 10x Genomics, Lowers Price Target to $65

Benzinga·11/09/2026 20:48:14
Listen to the news
JP Morgan analyst Casey Woodring maintains 10x Genomics (NASDAQ:TXG) with a Neutral and lowers the price target from $70 to $65.